Abstract:Pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are ligand-activated transcription factors that regulate the expression of drug metabolizing enzymes and drug transporters. Since their discoveries, they have been studied as important factors for regulating processes related to drug efficacy, drug toxicity, and drug-drug interactions. However, their vast ligand-binding profiles extend into additional spaces, such as endogenously produced chemicals, microbiome metabolites, dietary compounds, and environmental pollutants. Therefore, PXR and CAR can respond to an enormous abundance of stimuli, resulting in significant shifts in metabolic programs and physiologic homeostasis. Naturally, PXR and CAR have been implicated in various diseases related to homeostatic perturbations, such as inflammatory bowel disorders, diabetes, and certain cancers. Recent findings have injected the field with new signaling mechanisms and tools to dissect the complex PXR and CAR biology and have strengthened the potential for future PXR and CAR modulators in the clinic. Here, we describe the historical and ongoing importance of PXR and CAR in drug metabolism pathways and how this history has evolved into new mechanisms that regulate and are regulated by these xenobiotic receptors, with a specific focus on small molecule ligands. To effectively convey the impact of newly emerging research, we have arranged five diverse and representative key recent advances, four specific challenges, and four perspectives on future directions. SIGNIFICANCE STATEMENT PXR and CAR are key transcription factors that regulate homeostatic detoxification of the liver and intestines. Diverse chemicals bind to these nuclear receptors, triggering their transcriptional tuning of the cellular metabolic response. This minireview revisits the importance of PXR and CAR in pharmaceutical drug responses and highlights recent results with implications beyond drug metabolism.

Xenobiotic Receptors Car and Pxr

Regulation of Drug-Metabolizing Enzymes by Xenobiotic Receptors: PXR and CAR

Regulation of Nuclear Receptors PXR and CAR by Small Molecules and Signal Crosstalk: Roles in Drug Metabolism and Beyond

Nuclear Receptors PXR and CAR: Implications for Drug Metabolism Regulation, Pharmacogenomics and Beyond

The Roles of Xenobiotic Receptors: Beyond Chemical Disposition.

Roles of xenobiotic receptors in vascular pathophysiology.

Genomewide comparison of the inducible transcriptomes of nuclear receptors CAR, PXR and PPARα in primary human hepatocytes

Regulation of Pxr and Car by Protein-Protein Interaction and Signaling Crosstalk

A Functional Cross-Talk Between Liver X Receptor-Alpha And Constitutive Androstane Receptor Links Lipogenesis And Xenobiotic Responses

Mechanisms of Xenobiotic Receptor Activation: Direct Vs. Indirect

Activation of xenobiotic receptors: driving into the nucleus.

The role of pregnane X receptor (PXR) in substance metabolism

Differential Regulation Of Hepatic Cyp2b6 And Cyp3a4 Genes By Constitutive Androstane Receptor But Not Pregnane X Receptor

Advances in the Research of Pregnane X Receptor and Constitutive Androstane Receptor

Differences in Gene Regulation by Dual Ligands of Nuclear Receptors Constitutive Androstane Receptor (CAR) and Pregnane X Receptor (PXR) in HepG2 Cells Stably Expressing CAR/PXR

Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective

Functional crosstalk of CAR-LXR and ROR-LXR in drug metabolism and lipid metabolism.

Nuclear Hormone Receptors PXR and CAR and Metabolic Diseases

Pregnane X Receptor As the “sensor and Effector” in Regulating Epigenome

A Novel Pregnane X Receptor-Mediated and Sterol Regulatory Element-Binding Protein-Independent Lipogenic Pathway

Pregnane X receptor as the "sensor and effector" in regulating epigenome.